Radiation Therapy after surgery can decrease the chance of cancer returning in the breast and improve survival. Check out our video on Radiation Therapy for #BreastCancer to learn more about this treatment method. #bcsm #breastcancerawareness #radonc ow.ly/6IUg30mcmXf

The REQUITE Animation produced Animating Science shows why we founded the REQUITE and is available in 6 languages YouTube: see links on requite.eu/node/193 #ProstateCancer #Breastcancer #Lungcancer #radiotherapy #toxicity #PersonalTreatment

REQUITE animations highlight a #bettertogether approach to science and how to build cohorts to identify genetic variants that increase risk of radiotherapy toxicity. requite.eu/node/189 requite.eu/node/193

❗APPLICATIONS FOR PHD PROJECTS ARE NOW OPEN❗ bmh.manchester.ac.uk/study/research… We have a wide range of clinical and non clinical opportunities that will train the science leaders of the future!

REQUITE report on patient recruitment available online: requite.eu/node/200 In total, 4,438 patients with breast, prostate or lung cancer were recruited prospectively. 383 additional lung cancer patients were genotyped alongside the REQUITE cohorts. (additional lung cohorts)

REQUITE Report on SNP selection online! To report on the genotyping undertaken of blood samples collected in the observational study and processed by the CIGMR biobank. see:requite.eu/node/199 #SNPs #CNVs #RadiotherapyToxicity #PredictionModels.

Final REQUITE Dissemination report available! The aim of this report is to provide a final update on the outputs and dissemination activities of the REQUITE consortium. Thanks to the whole consortium including a very active #PatientAdvisoryGroup. see requite.eu/node/202

Were you involved in the #REQUITE study on radiotherapy Leicester's Hospitals? A new patient leaflet to say thanks & update you on the progress of the study is available here, in 7 languages requite.eu/node/184 REQUITE Hope Against Cancer

Very happy to have contributed with Vall d’Hebron Institute of Oncology (VHIO) Vall d'Hebron to REQUITE, #Europeanproject recruiting data, DNA and RNA samples from about 4300 #breastcancer #ProstateCancer #lungcancer patients to validate prediction models and biomarkers of radiotherapy-induced side effects

Chris Talbot talking about how circadium rythmn genetic variants affect risk of toxicity when radiotherapy is given am or pm.

Collecting data from 4438 #Cancer patients, the REQUITE aims to identify biomarkers for radiotherapy toxicity to improve quality of life. VHIO's involvement led by Sara Gutiérrez-Enríquez and Radiation Oncology Department from Vall d'Hebron. Read more: vhio.net/en/predictive-…

Catharine West from RT Related Research illustrating risk modelling integrating polygenic risk scores with clinical / dosimetric NTCP data. Large international efforts such as REQUITE are essential. #medphys #radonc #ptcog58

"The Green Journal has just published an exciting new article describing the REQUITE project, from idea to present status." bit.ly/2KhTqoc

Thanks to patient-derived samples from REQUITE, we are going to investigate if #microRNAs from blood are #biomarkers of long-term-side effects of #radiotherapy in #breastcancer and #prostatecancer patients!